New Treatment Regimen for Latent Tuberculosis Infection - once a week, for 12 weeks (CDC video)

Dr. Kenneth Castro discusses the CDC guidelines for the use of a new regimen for the treatment of persons with latent tuberculosis infection. This is based on the 12-dose regimen for the treatment of latent TB infection (LTBI) - rifapentine and isoniazid once a week, for 12 weeks.

Normal Side Effects include the fact that rifapentine may cause urine, saliva, tears, or sweat to
appear an orange-red color. This is normal. If saliva and tears turn an orange-red color, contact lenses or dentures worn during treatment may become permanently stained.


CDC | TB | Treatment for Latent TB Infection (LTBI)

No comments:

Post a Comment